Carcinoembryonic antigen in gynecologic cancers. Immunohistochemical localization and serum levels. 1983

J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski

The presence of carcinoembryonic antigen (CEA)-dependent fluorescence was observed in almost 89% of female genital tract cancers irrespective of their histologic type. Anti-CEA serum was free of antibody to normal cross-reacting antigen. The high percentage of positive fluorescence tests did not correlate with the preoperative serum CEA levels. Double immunodiffusion tests showed different content of CEA and normal cross-reacting antigen in individual specimens of genital tract cancers.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
January 1985, Cancer detection and prevention,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
June 2003, The Journal of thoracic and cardiovascular surgery,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
August 1978, Cancer,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
December 1977, Gynecologic oncology,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
July 1977, Archiv fur Gynakologie,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
April 1990, Oral surgery, oral medicine, and oral pathology,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
February 1980, Harefuah,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
June 1982, Cancer research,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
January 1985, Cancer,
J Kula, and A Harlozinska, and R Richter, and Z Albert, and J Sward, and W Gawlikowski
February 2018, Biomedicines,
Copied contents to your clipboard!